Pcn139 - Cost-Effectiveness Analysis of Pembrolizumab for Patients With Locally Advanced or Metastatic Urothelial Cancer Who Are Ineligible for Cisplatin-Containing Chemotherapy in England

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.222
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Pcn138 - Cost-Effectiveness Analysis of Pembrolizumab in Patients With Previously Treated Locally Advanced or Metastatic Urothelial Cancer in England

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Choosing Chemotherapy in Patients With Advanced Urothelial Cell Cancer Who Are Unfit to Receive Cisplatin-Based Chemotherapy

Therapeutic Advances in Medical Oncology
Oncology
2010English

Pcn178 - Cost-Effectiveness of Pembrolizumab as Second-Line Treatment for Patients With Advanced Urothelial Cancer in France

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Vinflunine in Platinum-Pretreated Patients With Locally Advanced or Metastatic Urothelial Carcinoma

Cancer
Cancer ResearchOncology
2009English

Pembrolizumab in the Treatment of Locally Advanced or Metastatic Urothelial Carcinoma: Clinical Trial Evidence and Experience

Therapeutic Advances in Urology
Urology
2019English

NeoadjuvantNab-paclitaxel and Gemcitabine in Borderline Resectable or Locally Advanced Unresectable Pancreatic Adenocarcinoma in Patients Who Are Ineligible for FOLFIRINOX

Anticancer Research
MedicineCancer ResearchOncology
2018English

Pcn148 - Cost-Effectiveness Analysis of Atezolizumab Compared to Treatment Options for Adult Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (Nsclc) After Prior Chemotherapy - Updated Results

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Cost-Effectiveness Analysis of Pembrolizumab Plus Chemotherapy for Previously Untreated Metastatic Non-Small Cell Lung Cancer in the USA

BMJ Open
Medicine
2019English

A Systematic Review of the Clinical Effectiveness of First-Line Chemotherapy for Adult Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Thorax
PulmonaryRespiratory Medicine
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy